Abstract
P53 is an anti-cancer protein for inducing cell cycle arrest and apoptosis. In glioblastoma multiform (GBM), p53 is able to induce apoptosis via inhibition of its negative regulator Mdm2. Experimental studies have shown that microRNA-25 (miR-25) can repress Mdm2 expression and, in turn, stabilizes p53 to induce the G1/S checkpoint in GBM cells. miR-25 expression is regulated by the cell cycle inducer molecule E2F1, which has been reported to induce apoptosis when overexpressed in GBM. However, the way p53, E2F1, and miR-25 coordinately regulate apoptosis induction in GBM is still obscure in the literature. In this study, we propose a logical model contemplating the regulatory influence of miR-25 and its regulator E2F1 on cell fate decision. Through in silico results for the wild-type case, we observed that miR-25 may stabilize p53 expression through Mdm2 inhibition inducing a G1/S checkpoint arrest or apoptosis in cells overexpressing E2F1. The predicted probabilities of our model are in good agreement with published experimental data. Moreover, we show that miR-25-induced p53 stabilization might contribute to apoptosis induction in GBM cells. These findings highlight some unrecognized mechanisms that may guide to alternative ideas for GBM therapeutic strategies.
Funding Information
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (145708/2017-9)

This publication has 58 references indexed in Scilit: